Table 1 Baseline characteristics and risk factors in patients with angiographically proven CAD, and previous MI as compared to controls without CAD.
Controls | CAD | p | CAD and MI | p | ||
|---|---|---|---|---|---|---|
Male | (n = 360) | (n = 1891) | (n = 1060) | |||
Female | (n = 333) | (n = 635) | (n = 279) | |||
Age (years) means ± SD | Male | 55 ± 12 | 63 ± 10 | 63 ± 10 | ||
Female | 62 ± 10 | 66 ± 10 | <0.0011 | 65 ± 10 | <0.0011 | |
Body mass index (kg/m2) means ± SD | Male | 27 ± 4 | 28 ± 4 | 27 ± 4 | ||
Female | 27 ± 5 | 27 ± 5 | n.s.2 | 27 ± 5 | n.s.2 | |
Smoker (former and current) | Male | 239 (66%) | 1487 (78%) | 867 (82%) | ||
Female | 100 (30%) | 253 (39%) | <0.0014 | 145 (51%) | <0.0014 | |
Diabetes mellitus | Male | 63 (17%) | 653 (34%) | 374 (35%) | ||
Female | 66 (20%) | 253 (39%) | <0.0014 | 120 (42%) | <0.0014 | |
Systemic Hypertension | Male | 212 (58%) | 1399 (74%) | 736 (69%) | ||
Female | 228 (69%) | 519 (81%) | 0.0024 | 220(77%) | n.s.4 | |
Fasting blood glucose (mmol/L) means ± SD | Male | 5,89 ± 1,67 | 6,39 ± 1,89 | 6,34 ± 1,83 | ||
Female | 5,78 ± 1,34 | 6,6 ± 2,44 | <0.0012 | 6,67 ± 2,5 | <0.0012 | |
LDL-C(mmol/L) means ± SD | Male | 3,02 ± 0,8 | 2,92 ± 0,85 | 2,84 ± 0,83 | ||
Female | 3,2 ± 0,8 | 3,2 ± 1,01 | 0.0023 | 3,05 ± 1,01 | n.s.3 | |
HDL-C (mmol/L) means ± SD | Male | 1,03 ± 0,28 | 0,93 ± 0,23 | 0,9 ± 0,23 | ||
Female | 1,19 ± 0,31 | 1,09 ± 0,28 | <0.0013 | 1,03 ± 0,28 | <0.0013 | |
Bilirubin (μmol/L) means ± SD | Male | 13,17 ± 7,53 | 11,46 ± 6,33 | 10.95 ± 5.82 | ||
Female | 9.58 ± 4,62 | 8,89 ± 6,16 | <0.0012 | 8,38 ± 4,10 | <0.0012 | |
Iron (μmol/L) | Male | 19,52 ± 8.06 | 16,66 ± 6,98 | 16,12 ± 6,98 | ||
Female | 17,19 ± 6,09 | 14,69 ± 5,91 | <0.0012 | 13,97 ± 5,91 | <0.0012 | |
Triglycerides (mmol/L) median (25th and 75th percentile) | Male | 1,64 (1,16–2,4) | 1,69 (1,26–2,27) | 1,7 (1,26–2,25) | ||
Female | 1,44 (1,04–2,01) | 1,73 (1,3–2,34) | <0.0123 | 1,75 (1,31–2,46) | n.s.3 |